Bright future for Domilens as Chiron increases world intra-ocular lenses IOL stake
This article was originally published in Clinica
Domilens' CEO Charles Roth-Meyer talked to Clinica's Jon Bryant about the company's takeover by Chiron and the future of intra-ocular lenses.
You may also be interested in...
The International Generic and Biosimilar Medicines Association has urged the World Intellectual Property Organization to withdraw its support for a global database of pharmaceutical patent information. The Pat-INFORMED database – which is comprised of intellectual-property information provided by originators – contains unverified data and lacks appropriate safeguards, the IGBA contends.
Reforms to the US 180-day exclusivity incentive included in the Blocking Act that is part of the Lower Health Care Costs Act could cost the US healthcare system approximately $1.7bn, the AAM has warned.